Tower Research Capital LLC (Trc) Lixte Biotechnology Holdings, Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.51 - $1.89 $3,012 - $11,164	-5,907 Reduced 87.61%	835 $1,000
Q4 2022 Feb 10, 2023	SELL	$0.48 - $6.0 $85 - $1,074	-179 Reduced 2.59%	6,742 $3,000
Q3 2022 Nov 10, 2022	BUY	$0.12 - $5.9 $142 - $6,997	1,186 Added 20.68%	6,921 $4,000
Q2 2022 Aug 15, 2022	BUY	$0.12 - $0.35 $358 - $1,044	2,984 Added 108.47%	5,735 $4,000
Q1 2022 May 12, 2022	SELL	$0.16 - $0.35 $153 - $336	-961 Reduced 25.89%	2,751 $3,000
Q4 2021 Feb 14, 2022	BUY	$0.21 - $0.57 $396 - $1,076	1,888 Added 103.51%	3,712 $4,000
Q3 2021 Nov 15, 2021	BUY	$0.52 - $0.85 $948 - $1,550	1,824 New	1,824 $4,000
Q2 2021 Aug 16, 2021	SELL	$0.46 - $0.89 $724 - $1,400	-1,574 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$0.8 - $1.2 $1,259 - $1,888	1,574 New	1,574 $5,000

Ticker LIXT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,646,600
Market Cap $33M
Description
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.